Stock Events

Stock Events

Spyre Therapeutics (3920.F) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-3.75

-2.72

-1.7

-0.67

Details

Expected EPS

-0.76317573473

Actual EPS

-1.2591016000000002

Surprise EPS

-0.5

Surprise Percent

+64.98%

Description

Spyre Therapeutics (3920.F) has reported earnings of -1.2591016000000002 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.